In addition, tumor-associated mutant p53 has been shown to bind and transcriptionally activate SREBP2 and activate the mevalonate pathway [143]; it is highly possible that p53 and SREBPs may potentially regulate each other. The gene discussed is TP53; the disease is neoplasm.